Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-Administration on the Pharmacokinetics of Neramexane.
Phase of Trial: Phase I
Latest Information Update: 18 Jan 2010
At a glance
- Drugs Neramexane (Primary) ; Clopidogrel
- Indications Alzheimer's disease; Coronary disorders; Thrombosis; Tinnitus
- Focus Pharmacokinetics
- Sponsors Merz Pharmaceuticals GmbH
- 11 Dec 2009 Actual end date (1 Dec 2009) added as reported by ClinicalTrials.gov.
- 11 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.